Abstract
No AccessJournal of UrologyAdult Urology1 Oct 2021Reply by Authorsis a reply to letterEditorial CommentEditorial Comment Neeraj Agarwal, Kelly McQuarrie, Anders Bjartell, Simon Chowdhury, Andrea J. Pereira de Santana Gomes, Byung Ha Chung, Mustafa Özgüroğlu, Álvaro Juárez Soto, Axel S. Merseburger, Hirotsugu Uemura, Dingwei Ye, Robert Given, Ethan Basch, Branko Miladinovic, Angela Lopez-Gitlitz, and Kim N. Chi Neeraj AgarwalNeeraj Agarwal *Correspondence: Huntsman Cancer Institute, University of Utah (NCI-CCC), 2000 Circle of Hope Dr., Suite 5726, Salt Lake City, Utah 84112 telephone: 801-213-5658; E-mail Address: [email protected] Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah More articles by this author , Kelly McQuarrieKelly McQuarrie Janssen Research & Development, Horsham, Pennsylvania More articles by this author , Anders BjartellAnders Bjartell Skåne University Hospital, Lund University, Malmö, Sweden More articles by this author , Simon ChowdhurySimon Chowdhury Guy’s, King’s, and St Thomas’ Hospitals, and Sarah Cannon Research Institute, London, United Kingdom More articles by this author , Andrea J. Pereira de Santana GomesAndrea J. Pereira de Santana Gomes Liga Norte Riograndense Contra O Câncer, Natal, Brazil More articles by this author , Byung Ha ChungByung Ha Chung Yonsei University College of Medicine and Gangnam Severance Hospital, Seoul, South Korea More articles by this author , Mustafa ÖzgüroğluMustafa Özgüroğlu Istanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, Istanbul, Turkey More articles by this author , Álvaro Juárez SotoÁlvaro Juárez Soto Hospital Universitario de Jerez de la Frontera, Cadiz, Spain More articles by this author , Axel S. MerseburgerAxel S. Merseburger University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany More articles by this author , Hirotsugu UemuraHirotsugu Uemura Kindai University Faculty of Medicine, Osaka, Japan More articles by this author , Dingwei YeDingwei Ye Fudan University Shanghai Cancer Center, Shanghai, China More articles by this author , Robert GivenRobert Given Urology of Virginia, Eastern Virginia Medical School, Norfolk, Virginia More articles by this author , Ethan BaschEthan Basch University of North Carolina, Chapel Hill, North Carolina More articles by this author , Branko MiladinovicBranko Miladinovic Janssen Research & Development, San Diego, California More articles by this author , Angela Lopez-GitlitzAngela Lopez-Gitlitz Janssen Research & Development, Los Angeles, California More articles by this author , and Kim N. ChiKim N. Chi BC Cancer, Vancouver, British Columbia, Canada More articles by this author View All Author Informationhttps://doi.org/10.1097/JU.0000000000001841.03AboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissionsReprints ShareFacebookLinked InTwitterEmail "Reply by Authors." The Journal of Urology, 206(4), p. 923 Reference 1. : Apalutamide in patients with metastatic castration-sensitive prostate cancer: final survival analysis of the randomized, double-blind, phase III TITAN study. J Clin Oncol 2021; 39: 2294. Google Scholar © 2021 by American Urological Association Education and Research, Inc.FiguresReferencesRelatedDetailsRelated articlesJournal of UrologyJul 23, 2021, 12:00:00 AMEditorial CommentJournal of UrologyJul 23, 2021, 12:00:00 AMEditorial Comment Volume 206Issue 4October 2021Page: 923-923 Advertisement Copyright & Permissions© 2021 by American Urological Association Education and Research, Inc.MetricsAuthor Information Neeraj Agarwal Huntsman Cancer Institute, University of Utah, Salt Lake City, Utah *Correspondence: Huntsman Cancer Institute, University of Utah (NCI-CCC), 2000 Circle of Hope Dr., Suite 5726, Salt Lake City, Utah 84112 telephone: 801-213-5658; E-mail Address: [email protected] More articles by this author Kelly McQuarrie Janssen Research & Development, Horsham, Pennsylvania More articles by this author Anders Bjartell Skåne University Hospital, Lund University, Malmö, Sweden More articles by this author Simon Chowdhury Guy’s, King’s, and St Thomas’ Hospitals, and Sarah Cannon Research Institute, London, United Kingdom More articles by this author Andrea J. Pereira de Santana Gomes Liga Norte Riograndense Contra O Câncer, Natal, Brazil More articles by this author Byung Ha Chung Yonsei University College of Medicine and Gangnam Severance Hospital, Seoul, South Korea More articles by this author Mustafa Özgüroğlu Istanbul University-Cerrahpaşa, Cerrahpaşa School of Medicine, Istanbul, Turkey More articles by this author Álvaro Juárez Soto Hospital Universitario de Jerez de la Frontera, Cadiz, Spain More articles by this author Axel S. Merseburger University Hospital Schleswig-Holstein, Campus Lübeck, Lübeck, Germany More articles by this author Hirotsugu Uemura Kindai University Faculty of Medicine, Osaka, Japan More articles by this author Dingwei Ye Fudan University Shanghai Cancer Center, Shanghai, China More articles by this author Robert Given Urology of Virginia, Eastern Virginia Medical School, Norfolk, Virginia More articles by this author Ethan Basch University of North Carolina, Chapel Hill, North Carolina More articles by this author Branko Miladinovic Janssen Research & Development, San Diego, California More articles by this author Angela Lopez-Gitlitz Janssen Research & Development, Los Angeles, California More articles by this author Kim N. Chi BC Cancer, Vancouver, British Columbia, Canada More articles by this author Expand All Advertisement Loading ...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.